Articles by Lori Clapper

31. Regulus and Biogen Idec Collaborate To Expand MS Research 8/11/2014
    Regulus Therapeutics, a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, has announced a collaboration with Biogen Idec to expand research focused on identifying microRNAs as biomarkers for multiple sclerosis (MS).
32. Onyx Scientific, Cancer Research UK To Partner On Range of Projects 7/29/2014
    Contract manufacturer Onyx Scientific is now managing a range of Cancer Research UK’s drug development projects, including the development and manufacturing of active pharmaceutical ingredients (API) for use in clinical trials.
33. Anacor And Sandoz Enter $40 Million Partnership For Antifungal Solution 7/24/2014

    Anacor Pharmaceuticals and Sandoz have inked an agreement, in which Sandoz’s dermatology business PharmaDerm will distribute and commercialize Anacor's antifungal drug Kerydin (tavaborole) topical solution in the United States. The U.S. Food and Drug Administration (FDA) approved the solution for the treatment of onychomycosis of the toenails earlier this month.

34. What Will Latest Price Caps In India Mean For Big Pharma? 7/16/2014
    India's pharmaceutical pricing regulator NPPA has cut and capped the prices of more than 100 drugs that treat diseases ranging from diabetes to HIV to malaria. The price cap, which officially took effect on July 11, 2014, is aimed to make essential medicines more affordable and accessible in India, where 70 percent of the population lives in extreme poverty and nearly all of its population is without health insurance.
35. Purdue Pharma's Pain Med Gets FDA Priority Review Status 7/10/2014

    On Tuesday, the U.S. Food & Drug Administration (FDA) granted priority review to Purdue Pharma’s once-daily, single-entity hydrocodone bitartrate tablet (HYD). The company’s investigational pain medication is designed to make it difficult for people to abuse, either through chewing, snorting, or intravenous means, according to Purdue’s announcement.

36. Study Finds Pharma Manufacturing Model Impedes Innovation 4/28/2014

    CPhI, a provider of innovative, interactive, and educational programs to network, learn, and gain new insights into the world of pharma, released new insights last week into current pharmaceutical manufacturing practices and processes.

37. Serialization Compliance: Will Pharma Be Prepared? Part 1 5/2/2013

    A Q&A With Chip Meyers, VP of UPS corporate public affairs, and Tim Bishop, manager of healthcare compliance, UPS

38. Serialization Compliance: Will Pharma Be Prepared? Part 2 5/2/2013

    A Q&A With Chip Meyers, VP of UPS corporate public affairs, and Tim Bishop, manager of healthcare compliance, UPS